Bausch Health Companies (BHC) Total Non-Current Liabilities (2009 - 2026)

Bausch Health Companies (BHC) reported Total Non-Current Liabilities of $24.8 billion for Q1 2026, down 4.18% on a YoY basis from $25.9 billion in Q1 2025, and down 1.5% sequentially from $25.2 billion in Q4 2025.

Bausch Health Companies (BHC) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Total Non-Current Liabilities data on file, last reported at $24.8 billion in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 4.18% year-over-year to $24.8 billion; the trailing twelve-month figure through Mar 2026 stood at $24.8 billion (down 4.18% YoY), and the FY2025 full-year result was $25.2 billion, down 3.58% from the prior year.
  • Total Non-Current Liabilities fell to $24.8 billion in Q1 2026, from $25.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $28.7 billion in Q1 2022 to a low of $24.5 billion in Q2 2023.
  • A 5-year average of $25.9 billion and a median of $26.0 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • Peak annual rise in Total Non-Current Liabilities reached 7.98% in 2023, while the deepest fall reached 14.41% in 2023.
  • Tracing BHC's Total Non-Current Liabilities over 5 years: stood at $24.7 billion in 2022, then increased by 7.98% to $26.7 billion in 2023, then decreased by 1.97% to $26.1 billion in 2024, then slipped by 3.58% to $25.2 billion in 2025, then retreated by 1.5% to $24.8 billion in 2026.
  • Business Quant data shows BHC's Total Non-Current Liabilities at $24.8 billion in Q1 2026, $25.2 billion in Q4 2025, and $25.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 24.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.82 Bn
Dec 31, 2025 25.20 Bn
Sep 30, 2025 25.63 Bn
Jun 30, 2025 26.24 Bn
Mar 31, 2025 25.90 Bn
Dec 31, 2024 26.13 Bn
Sep 30, 2024 25.98 Bn
Jun 30, 2024 25.98 Bn
Mar 31, 2024 26.34 Bn
Dec 31, 2023 26.66 Bn
Sep 30, 2023 26.58 Bn
Jun 30, 2023 24.49 Bn
Mar 31, 2023 24.55 Bn
Dec 31, 2022 24.69 Bn
Sep 30, 2022 25.25 Bn
Jun 30, 2022 27.39 Bn
Mar 31, 2022 28.69 Bn
Dec 31, 2021 28.58 Bn
Sep 30, 2021 28.52 Bn
Jun 30, 2021 29.68 Bn